Browse all 653 ETFs by category, no search needed
Global 187
US market 62
Country 93
Core UCITS 15
Sector 103
Style & factor 111
Theme 45
Dividend 37
Global X Aging Population (AGNG)Overvalued or undervalued?
Look-through valuation · Global · Expense ratio 0.52 % · ISIN US37954Y7720
Price history (since 2016)
Monthly close since 2016. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
| Holding | Weight | vs fair value | Quality |
|---|---|---|---|
| AbbVie Inc ABBV | 4.0 % | −9.1 % | 74 |
| Eli Lilly and Company LLY | 4.0 % | −41.2 % | 67 |
| Amgen Inc AMGN | 3.6 % | +12.0 % | 64 |
| Roche Holding AG RO | 3.5 % | −19.0 % | 75 |
| Merck & Company Inc MRK | 3.4 % | −11.0 % | 67 |
| Edwards Lifesciences Corp EW | 3.2 % | −7.9 % | 67 |
| Welltower Inc WELL | 3.2 % | −68.4 % | 42 |
| Johnson & Johnson JNJ | 3.1 % | −36.0 % | 80 |
| Bristol-Myers Squibb Company BMY | 3.1 % | +23.6 % | 78 |
| Regeneron Pharmaceuticals Inc REGN | 3.1 % | +58.4 % | 73 |
| Medtronic PLC MDT | 3.1 % | −31.2 % | 69 |
| Novo Nordisk A/S Class B 0QIU | 3.0 % | n/a | n/a |
| Ventas Inc VTR | 3.0 % | −60.5 % | 44 |
| Sandoz Group AG SDZ | 2.8 % | −51.2 % | 56 |
| BeiGene Ltd BGNE | 2.7 % | n/a | n/a |
| Stryker Corporation SYK | 2.7 % | +10.0 % | 68 |
| AstraZeneca PLC AZN | 2.4 % | −25.9 % | 69 |
| Celltrion Inc 068270 | 2.4 % | −60.6 % | 50 |
| Alcon AG ALC | 2.2 % | n/a | n/a |
| UCB SA UCB | 2.1 % | −33.7 % | 80 |
| DexCom Inc DXCM | 2.1 % | +10.0 % | 83 |
| Chugai Pharmaceutical Co. Ltd. 4519 | 2.1 % | n/a | n/a |
| Boston Scientific Corp BSX | 2.0 % | +10.0 % | 68 |
| Astellas Pharma Inc. 4503 | 1.9 % | n/a | n/a |
| Hansoh Pharmaceutical Group Co Ltd 3692 | 1.7 % | +14.9 % | 73 |
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 83 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
The 10 most cheaply valued ETFs
Measured against the look-through fair value of the holdings (sufficiently covered funds only). Green means below fair value, red above. Not financial advice.
- 1 KWEB KraneShares CSI China Internet ETF 50.0 % below FV
- 2 CHIQ Global X MSCI China Consumer Disc ETF 49.1 % below FV
- 3 CHIU Global X MSCI China Utilities ETF 44.8 % below FV
- 4 MCHI iShares MSCI China ETF 36.2 % below FV
- 5 FLCH Franklin FTSE China ETF 35.7 % below FV
- 6 FDNI First Trust Dow Jones International Internet ETF 28.9 % below FV
- 7 FCFY First Trust S&P 500 Diversified Free Cash Flow ETF 26.1 % below FV
- 8 ITB iShares U.S. Home Construction ETF 23.0 % below FV
- 9 FDEM Fidelity® Emerging Markets Multifactor ETF 17.1 % below FV
- 10 TAN Invesco Solar ETF 16.6 % below FV
Frequently asked about AGNG
Is AGNG overvalued?
What is the fair value of AGNG?
How do you calculate the fair value of an ETF?
Which stocks drive the valuation of AGNG?
What is the expense ratio of AGNG?
How we value this ETF
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives Global X Aging Population ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Oct 27, 2026
The look-through is a computed summary of public fundamentals and is no substitute for your own research.